The Patent Finder

Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists

Novartis Pharma AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/EP2011/069476, filed Nov 4, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,363,307Methods of Treating Psoriatic Arthritis Using IL-17 Antagonists
In force
 · Medium confidence
UsedRemaining
Novartis AGIn forceMedium confidence
US 12,465,635Methods of Treating Inflammatory Arthritis Using Secukinumab
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 12,594,333Methods of Treating Inflammatory Arthritis Using IL-17 Antagonists
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
US 11,534,491Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,744,234Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
Application 16/439,423Methods of Treating Psoriatic Arthritis Using IL-17 Antagonists
Abandoned
Abandoned Dec 18, 2021
Novartis AGAbandonedAbandoned Dec 18, 2021
Application 17/127,758Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
Abandoned
Abandoned Nov 18, 2022
Novartis AGAbandonedAbandoned Nov 18, 2022
Application 17/165,729Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
Abandoned
Abandoned Oct 22, 2022
Novartis AGAbandonedAbandoned Oct 22, 2022
Application 18/048,797Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
Abandoned
Abandoned Oct 27, 2026
Novartis Pharma AGAbandonedAbandoned Oct 27, 2026
Application 18/061,221Methods of Treating Ankylosing Spondylitis Using IL-17 Antagonists
Pending
Not granted
Novartis Pharma AGPendingNot granted
1 more record in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
2 of these are in force and held by Novartis Pharma AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited